RecruitingNCT06725576

Ultrasound-Guided Microwave Ablation Vs. Surgery for Low-Risk PapilaryThyroid Carcinoma

Ultrasound and Gene-Guided Microwave Ablation Versus Surgery for Low-Risk Papillary Thyroid Carcinoma: a Prospective Observational Cohort Study.


Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Enrollment

201 participants

Start Date

Jan 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to investigate the efficacy and prognosis of ultrasound-guided and gene-based microwave ablation (MWA) versus surgical treatment in patients with low-risk papillary thyroid carcinoma (PTC). By analyzing genetic testing results, the study explores the impact of genetic mutations on treatment selection for low-risk patients, providing more precise molecular biological evidence for treatment choices and prognosis evaluation of thyroid cancer. This prospective study collects clinical data from patients diagnosed with PTC at Sun Yat-sen Memorial Hospital of Sun Yat-sen University between January 2022 and November 2024, who underwent genetic testing prior to treatment, and assesses efficacy and complications through long-term follow-up.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This study compares microwave ablation (a heat-based procedure to destroy tumors using a needle) versus surgery for treating small, low-risk papillary thyroid cancer, to see if ablation is equally safe and effective while being less invasive. **You may be eligible if...** - Have papillary thyroid carcinoma (a common, typically slow-growing thyroid cancer) confirmed by fine-needle aspiration biopsy - Tumor has a confirmed low-risk genetic mutation profile - Do not have serious organ failure (heart, lungs, or kidneys) **You may NOT be eligible if...** - Have a high-risk or aggressive genetic mutation in your thyroid tumor - Have already had thyroid surgery or radiation - Have cancer that has spread to lymph nodes or distant sites - Have serious heart, lung, or kidney problems Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREAblation

Thyroid ablation performed under ultrasound guidance to treat low-risk papillary thyroid carcinoma.


Locations(1)

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

Guangzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06725576


Related Trials